IL6R and amyotrophic lateral sclerosis: Hypothesizing that humoral IL-6-mediated inflammation triggers EC damage, then restoration of EC integrity with an anti-inflammatory agent(s) preventing IL-6/sIL-6R complex formation or inhibiting membrane trans-signaling sIL-6R/gp130, may afford vascular repair in ALS.